Lecture 11 - ECM stiffness, fibrosis and cancer Flashcards

1
Q

The extracellular matrix

A

The mechanical properties of most tissues are defined by their matrix

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Matrisome: what is it made of, what two types are there, and what features define its mechanical properties?

A

Matrisome proteins - proteins that compose or associate with the ECM - are classified as:

  • Core Matrisome - structural components: collagens, glycoproteins and proteoglycans
  • Matrisome-Associated - secreted proteins that associate with or modify the ECM

The following features of the matrix define its mechanical properties:
* Identity of matrix proteins
* Concentration of matrix proteins
* How proteins are organized
* Whether matrix proteins are crosslinked together
* Some tissues also contain mineral deposits (e.g., bone)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Mass spec

A
  • Disrupting and solubilising tissues to get proteins
  • Using trypsin to digest the protein
  • Using liquid chromatography coupled tandem mass spectrometry (LC-MS/MS)
  • Obtaining bioinformatics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Core matrisome: how much of it is composed of proteins, what do collagens, proteoglycans, and glycoproteins do?

A

20% mass is proteins

Collagens - structural components of connective tissues, using a repeating sequence of amino acids allows the formation of triple-helical structures, that assemble into fibrils

Proteoglycans (e.g., perlecan, biglycan, lumican):
Proteins functionalized with glycosaminoglycans (GAGs; repeating polymers of disaccharides) bind to water, salts and soluble factors; fill space in the ECM and provide lubrication

Glycoproteins (e.g., fibronectin, laminins):
Proteins functionalized with complex oligosaccharide chains, provide a range of functions: ECM assembly; cell adhesion; signalling; binding growth factors etc.

The matrisome can be studied in different tissues and resolved spatially and by time and is affected by disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Matrix proteins

A

Many matrix proteins behave as “biological polymers” - Higher concentrations increase stiffness, strength highest when along a length (ie, a tendon)

Assembly and orientation therefore influence the strength

Cross-linking can bind ECM molecules together, increasing the stiffness of tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

hallmarks of cancer

A

Although the specific mutations and affected pathways may differ, most cancers acquire the same functional capabilities - the ‘hallmarks of cancer’

The matrices of healthy tissues, cancers and sites of metastasis are different - although there are many shared proteins, they all have many differences too

  • Sustaining proliferative signalling
  • Evading growth suppressors
  • Avoiding immune destruction
  • Enabling replicative immortality
  • Tumour-promoting inflammation
  • Activating invasion and metastasis
  • Inducing angiogenesis
  • Genome instability and mutation
  • Resisting cell death
  • Deregulating cellular energetics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

ECM protein receptors: what examples are there, and what do they do?

A

DDR, integrin receptors, etc

Bind to ECM proteins and activate several pathways

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What types of cell behaviours can be influenced by mechanical signals?

A

The following cell behaviours can be influenced by mechanical signals:
* Cell morphology (e.g., spreading and shape)
* Contractility (how hard cells pull on their surroundings)
* Propagation rate and apoptosis
* Cell movement
* Differentiation (commitment to lineage)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Matrix-regulated pathways: FAK, MAPK/ERK, VEGF, Rho/ROCK/Rac.

A

Focal adhesion kinase (FAK) signalling limits sensitivity to growth inhibitors and apoptosis

Mitogen-activated protein kinase (MAPK) and extracellular-signal-regulated kinase (ERK) signalling promotes cell proliferation

Vascular endothelial growth factor (VEGF) signalling induces angiogenesis

Rho/ROCK and Rac signalling drive invasion and metastasis

Immune cell activity can be modulated by extracellular matrix

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Breast cancer: what is it, how frequent is it, what are the statistics, and how does diagnosis work?

A

Breast cancer is one of the most prevalent tumour types

Lifetime risk is 1-in-8 for women.

55,000 diagnoses per year in the UK, and 1.5 million worldwide.

Results in death in 1-in-5 cases in the UK, 1-in-3 worldwide

Mammography uses low-intensity X-rays to look for characteristic masses in breast tissue - tumours are seen as regions of very high mammographic density (MD) - High MD is the most significant risk factor for breast cancer after ageing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

High MD: what is it, what is it the most significant risk factor for, and what do elevated MD levels correlate with?

A

High MD tissue is stiffer

High MD is the most significant risk factor for breast cancer after ageing

Areas of elevated MD correlate with increased fibrillar collagen & higher fibre organization

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What occurs in the ECM as a tumour develops

A

Epithelial cell begins uncontrolled cell proliferation

Increased matrix production - e.g., by fibroblasts

Increased crosslinking - ie, by enzyme lysyl oxidase, LOX

Reorganisation of matrix - e.g., by proteases

Cancer cells invade ECM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

CAFs: what are they, what relation to cancer do they have, and what physiological effects do they cause?

A

Cancer-associated fibroblasts

Solid tumour formation can be considered as a fibrotic process

  • Growth of tumour
  • Recruitment of fibroblasts.
  • Excessive matrix
  • Tissue stiffening
  • inflammation
  • Metastasis
  • Organ failure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Metastasis: what does it require and what limits does it have?

A
  • Enzymatic matrix remodelling
  • Cell deformation

Invasion into surrounding tissue is limited by the cell’s ability to degrade the matrix, or to squeeze through small gaps - typically the nucleus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

The nucleus: what is its size as an organelle, how is it attached to the cytoskeleton, what determines its stiffness, and what is its role in metastasis?

A

Typically the largest and stiffest organelle

Attached to the cytoskeleton by IF, MT, and actin

Stiffness is determined by lamin proteins in the nuclear envelope - Lamin A (viscous), lamin B (elastic)

More lamin: metastasis inhibited

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Lamin A-KD: what is its role in tumour growth?

A

Knockdown (KD) of lamin-A makes tumors grow more rapidly

17
Q

Lamin A: can it be used as a cancer marker or as a treatment?

A

The role of lamin in cancer is complex: some cancers show increased malignancy with lamin-A, while others show the opposite effect.

18
Q

ECM cross-linking

A

Extracellular enzymes can remodel the matrix. Enzymatic processes may crosslink and therefore stiffen the extracellular matrix.

19
Q

Action of transglutaminase (TGM)

A

Linking two peptides (P1 and P2) in the ECM

20
Q

LOX: what is it, what is its role in the extracellular matrix, how does it affect tumour metastasis, and what is its shown role in mouse tissue?

A

Lysyl oxidase - an extracellular copper-dependent enzyme that catalyses the formation of aldehydes from lysine residues in collagen and elastin precursors

Can either promote or inhibit metastasis dependent on the tissue (complex) by making the ECM more rigid (easier to navigate through) and activating tumour-promoting pathways - ie tumour-associated fibroblasts (TAFs) activation

Mouse tissue treated with LOX-expressing fibroblast cells (FB.LOX) contained more fibrillar collagen and was stiffer

21
Q

What are two extracellular enzymes that can degrade the ECM?

A
  • Matrix MetalloProteinase (MMP) family
  • A Disintegrin And Metalloproteinase ThromboSpondin motif (ADAMTS) family
22
Q

MMP family: what is it, what do they do, what modulates their activity, what are the key features of the family, and what are their roles in cancer?

A

Range of ECM substrates

Tissue remodeling and organ development and regulation of inflammatory processes, etc

Activity can be modulated by TIMPs (tissue inhibitors of metalloproteinases)

  • Zn ion in active enzymatic site
  • Soluble and membrane-bound

MMP-family proteins are involved in many cancer hallmarks and, like LOX, their role in disease is complex

23
Q

ADAMTS: what are they and what do they do?

A

A Disintegrin And Metalloproteinase ThromboSpondin motif

  • Collagen processing
  • Proteoglycan cleavage
24
Q

How do cancer cells produce a distinct cancer matrix?

A

Cancer cells and CAFs produce a distinct cancer matrix, by:

  • Secreting new matrix proteins.
  • Crosslinking matrix, e.g., with LOX-family enzymes
  • Degrading or remodelling matrix, e.g., with MMP/ADAMTS-family enzymes
25
Q

What limits are there to cancer metastasising?

A

Deformability of the cell and nucleus

Degradation or cross-linking of the matrix